162 related articles for article (PubMed ID: 14991042)
1. Aurora kinases dawn as cancer drug targets.
Sausville EA
Nat Med; 2004 Mar; 10(3):234-5. PubMed ID: 14991042
[No Abstract] [Full Text] [Related]
2. Aurora A and B kinases as targets for cancer: will they be selective for tumors?
Matthews N; Visintin C; Hartzoulakis B; Jarvis A; Selwood DL
Expert Rev Anticancer Ther; 2006 Jan; 6(1):109-20. PubMed ID: 16375648
[TBL] [Abstract][Full Text] [Related]
3. Polo and Aurora kinases: lessons derived from chemical biology.
Taylor S; Peters JM
Curr Opin Cell Biol; 2008 Feb; 20(1):77-84. PubMed ID: 18249108
[TBL] [Abstract][Full Text] [Related]
4. Aurora kinases as anticancer drug targets.
Gautschi O; Heighway J; Mack PC; Purnell PR; Lara PN; Gandara DR
Clin Cancer Res; 2008 Mar; 14(6):1639-48. PubMed ID: 18347165
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of Aurora kinase inhibitors in cancer.
Naruganahalli KS; Lakshmanan M; Dastidar SG; Ray A
Curr Opin Investig Drugs; 2006 Dec; 7(12):1044-51. PubMed ID: 17209521
[TBL] [Abstract][Full Text] [Related]
6. Aurora kinases: new targets for cancer therapy.
Carvajal RD; Tse A; Schwartz GK
Clin Cancer Res; 2006 Dec; 12(23):6869-75. PubMed ID: 17145803
[TBL] [Abstract][Full Text] [Related]
7. Aurora A: target invalidated?
Cochran AG
Chem Biol; 2008 Jun; 15(6):525-6. PubMed ID: 18559262
[TBL] [Abstract][Full Text] [Related]
8. Aurora kinase inhibitors as anti-cancer therapy.
Lok W; Klein RQ; Saif MW
Anticancer Drugs; 2010 Apr; 21(4):339-50. PubMed ID: 20016367
[TBL] [Abstract][Full Text] [Related]
9. Is there a future for Aurora kinase inhibitors for anticancer therapy?
Carpinelli P; Moll J
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
[TBL] [Abstract][Full Text] [Related]
10. Aurora-kinase inhibitors as anticancer agents.
Keen N; Taylor S
Nat Rev Cancer; 2004 Dec; 4(12):927-36. PubMed ID: 15573114
[TBL] [Abstract][Full Text] [Related]
11. Targeting polo-like kinase: learning too little too late?
Olmos D; Swanton C; de Bono J
J Clin Oncol; 2008 Dec; 26(34):5497-9. PubMed ID: 18955441
[No Abstract] [Full Text] [Related]
12. PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity.
Soncini C; Carpinelli P; Gianellini L; Fancelli D; Vianello P; Rusconi L; Storici P; Zugnoni P; Pesenti E; Croci V; Ceruti R; Giorgini ML; Cappella P; Ballinari D; Sola F; Varasi M; Bravo R; Moll J
Clin Cancer Res; 2006 Jul; 12(13):4080-9. PubMed ID: 16818708
[TBL] [Abstract][Full Text] [Related]
13. New targets for cancer chemotherapy.
Arbuck SG; Dancey J; Pluda JM; Grochow L; Murgo AJ; Ivy P; Wright J; Blaylock B; Via LE; Sausville EA
Cancer Chemother Biol Response Modif; 2001; 19():237-88. PubMed ID: 11686017
[No Abstract] [Full Text] [Related]
14. Discovery and development of aurora kinase inhibitors as anticancer agents.
Pollard JR; Mortimore M
J Med Chem; 2009 May; 52(9):2629-51. PubMed ID: 19320489
[No Abstract] [Full Text] [Related]
15. [Inhibitors of aurora kinases].
Pinel S; Barbault-Foucher S; Lott-Desroches MC; Astier A
Ann Pharm Fr; 2009 Mar; 67(2):69-77. PubMed ID: 19298889
[TBL] [Abstract][Full Text] [Related]
16. Divide and conquer: new generation of drugs targets mitosis.
Garber K
J Natl Cancer Inst; 2005 Jun; 97(12):874-6. PubMed ID: 15956646
[No Abstract] [Full Text] [Related]
17. MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
Huck JJ; Zhang M; McDonald A; Bowman D; Hoar KM; Stringer B; Ecsedy J; Manfredi MG; Hyer ML
Mol Cancer Res; 2010 Mar; 8(3):373-84. PubMed ID: 20197380
[TBL] [Abstract][Full Text] [Related]
18. PLK1 as an oncology target: current status and future potential.
McInnes C; Wyatt MD
Drug Discov Today; 2011 Jul; 16(13-14):619-25. PubMed ID: 21601650
[TBL] [Abstract][Full Text] [Related]
19. Mitotic drivers--inhibitors of the Aurora B Kinase.
Keen N; Taylor S
Cancer Metastasis Rev; 2009 Jun; 28(1-2):185-95. PubMed ID: 19189202
[TBL] [Abstract][Full Text] [Related]
20. SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo.
Arbitrario JP; Belmont BJ; Evanchik MJ; Flanagan WM; Fucini RV; Hansen SK; Harris SO; Hashash A; Hoch U; Hogan JN; Howlett AR; Jacobs JW; Lam JW; Ritchie SC; Romanowski MJ; Silverman JA; Stockett DE; Teague JN; Zimmerman KM; Taverna P
Cancer Chemother Pharmacol; 2010 Mar; 65(4):707-17. PubMed ID: 19649632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
